Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine - United States, December 14-23, 2020.

CDC COVID-19 Response Team, Food and Drug Administration. · 2021

Read Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine - United States, December 14-23, 2020. by CDC COVID-19 Response Team, Food and Drug Administration. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7808711.txt.

Description

The CDC COVID-19 Response Team, with the Food and Drug Administration, reports allergic reactions after the first Pfizer-BioNTech vaccine doses. The report covers the United States from December 14 to 23, 2020. The vaccine had gained emergency use approval on December 11.

Cases include anaphylaxis, a severe allergic reaction. By January 3, 2021, the country had logged 20,346,372 COVID-19 cases. Deaths stood at 349,246. Against that backdrop, reaction reports were tracked closely. The document sets out what was seen in the first days of rollout. It gives clinicians guidance on spotting and treating such reactions. All 20 people with follow-up information had recovered or been discharged home.

Catalog record

CREATORCDC COVID-19 Response Team, Food and Drug Administration.
YEAR2021
COLLECTIONPAPERS
FORMATTXT
FILE SIZE20 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC7808711

Browse the full library · About the Tower of Babel